Literature DB >> 10411484

Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?

A Scozzafava1, L Menabuoni, F Mincione, F Briganti, G Mincione, C T Supuran.   

Abstract

Reaction of several aromatic/heterocyclic sulfonamides containing a free amino, imino, hydrazino, or hydroxyl group, with 2, 3-pyridinedicarboxylic anhydride or 2,6-pyridinedicarboxylic acid in the presence of carbodiimide derivatives, afforded two series of water-soluble (as hydrochloride, triflate, or carboxylate salts) compounds. The new derivatives were assayed as inhibitors of the zinc enzyme carbonic anhydrase (CA) and more precisely of three of its isozymes, CA I, II (cytosolic forms), and IV (membrane-bound form), involved in important physiological processes. Efficient inhibition was observed against all three isozymes, but especially against CA II and IV (in nanomolar range), the two isozymes known to play a critical role in aqueous humor secretion within the ciliary processes of the eye. Some of the best inhibitors synthesized were applied as 2% water solutions directly into the eye of normotensive and glaucomatous albino rabbits. Very strong and long-lasting intraocular pressure (IOP) lowering was observed with many of them. This result prompted us to reanalyze the synthetic work done by other groups for the design of water-soluble, topically effective antiglaucoma sulfonamides. According to these researchers, the IOP-lowering effect is due to the intrinsic nature of the specific heterocyclic sulfonamide considered, among which the thienothiopyran-2-sulfonamide derivatives represent the best-studied case. Indeed, the first agents developed for topical application, such as dorzolamide, are derivatives of this ring system. To prove that the tail (in this case the pyridinecarboxylic moieties) conferring water solubility to a sulfonamide CA inhibitor is more important than the ring to which the sulfonamido group is grafted, we also prepared dorzolamide derivatives incorporating such moieties. These new compounds possess good water solubility as hydrochloride or carboxylate salts, balanced by a relatively modest lipid solubility. They are strong CA II inhibitors and are able to lower IOP in experimental animals more than the parent derivatives. Our conclusion is that the tail conferring water solubility to such an enzyme inhibitor is more important for topical activity as an antiglaucoma drug, than the heterocyclic/aromatic ring to which the sulfonamido moiety is grafted.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411484     DOI: 10.1021/jm9900523

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  24 in total

1.  Coumarinyl-substituted sulfonamides strongly inhibit several human carbonic anhydrase isoforms: solution and crystallographic investigations.

Authors:  Jason Wagner; Balendu Sankara Avvaru; Arthur H Robbins; Andrea Scozzafava; Claudiu T Supuran; Robert McKenna
Journal:  Bioorg Med Chem       Date:  2010-06-15       Impact factor: 3.641

2.  Self-assembled polymer vesicles in deciding action of Zn-sulfanilamide allergenicity.

Authors:  Sankar Prasad Paik; Pallabi Samaddar; Souvik Sen; Kamalika Sen
Journal:  Drug Deliv Transl Res       Date:  2014-12       Impact factor: 4.617

Review 3.  Clinical pharmacokinetics of dorzolamide.

Authors:  Jens Martens-Lobenhoffer; Peter Banditt
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 4.  Carbonic anhydrase XII inhibition overcomes P-glycoprotein-mediated drug resistance: a potential new combination therapy in cancer.

Authors:  Kathryn F Tonissen; Sally-Ann Poulsen
Journal:  Cancer Drug Resist       Date:  2021-06-19

5.  Response to Perspectives on the Classical Enzyme Carbonic Anhydrase and the Search for Inhibitors.

Authors:  Andrea Angeli; Fabrizio Carta; Alessio Nocentini; Jean-Yves Winum; Raivis Zalubovskis; Valentina Onnis; Wagdy M Eldehna; Clemente Capasso; Simone Carradori; William A Donald; Shoukat Dedhar; Claudiu T Supuran
Journal:  Biophys J       Date:  2020-12-08       Impact factor: 4.033

6.  A class of 4-sulfamoylphenyl-ω-aminoalkyl ethers with effective carbonic anhydrase inhibitory action and antiglaucoma effects.

Authors:  Murat Bozdag; Melissa Pinard; Fabrizio Carta; Emanuela Masini; Andrea Scozzafava; Robert McKenna; Claudiu T Supuran
Journal:  J Med Chem       Date:  2014-11-10       Impact factor: 7.446

7.  A class of carbonic anhydrase I - selective activators.

Authors:  Erol Licsandru; Muhammet Tanc; Istvan Kocsis; Mihail Barboiu; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2016-11-01       Impact factor: 5.051

8.  Enhanced Ibuprofen Adsorption and Desorption on Synthesized Functionalized Magnetic Multiwall Carbon Nanotubes from Aqueous Solution.

Authors:  Ghadir Hanbali; Shehdeh Jodeh; Othman Hamed; Roland Bol; Bayan Khalaf; Asma Qdemat; Subhi Samhan
Journal:  Materials (Basel)       Date:  2020-07-27       Impact factor: 3.623

9.  Inhibition studies on a panel of human carbonic anhydrases with N1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails.

Authors:  Fadi M Awadallah; Silvia Bua; Walaa R Mahmoud; Hossam H Nada; Alessio Nocentini; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

10.  Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.

Authors:  P V Sri Ramya; Srinivas Angapelly; Andrea Angeli; Chander Singh Digwal; Mohammed Arifuddin; Bathini Nagendra Babu; Claudiu T Supuran; Ahmed Kamal
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.